Sintón Hispania, S.L. (manufacturing "in bulk", primary and secondary packaging, physicochemical testing, responsible for batch release)

Ukraine

All drugs from this manufacturer

  • ANAGRELIDE ZENTIVA

    The drug is intended to reduce platelet levels in patients at high risk of developing essential thrombocythemia if current treatment is ineffective or not tolerated by the patient.

    Dosage form: capsules, hard

    Active substance Dosage
    anagrelide 0.5 mg

    ATC: L01XX35

  • ANAGRELIDE ZENTIVA

    The drug is intended to reduce platelet levels in patients at high risk of developing essential thrombocythemia if other treatment methods are ineffective or not tolerated by the body.

    Dosage form: capsules, hard

    Active substance Dosage
    anagrelide 1 mg

    ATC: L01XX35